Literature DB >> 31077882

Screening of a large cohort of blepharophimosis, ptosis, and epicanthus inversus syndrome patients reveals a very strong paternal inheritance bias and a wide spectrum of novel FOXL2 mutations.

David J Bunyan1, N Simon Thomas2.   

Abstract

Blepharophimosis, Ptosis, and Epicanthus inversus Syndrome (BPES) is caused by autosomal dominant mutations in FOXL2. There are two forms of BPES: type I (with primary ovarian insufficiency (POI)) and type II (without POI). Data are presented from a large cohort of 177 BPES probands. Diagnostic testing identified a wide range of mutations in 119 mutation-positive patients (including 38 novel mutations). Although FOXL2 mutations are distributed throughout the gene, over 50% were frameshift mutations within a hotspot region of the gene that can be detected using a single primer pair to provide a cost-effective and rapid screening method. There was a significant proportion of de novo cases in this study, although in 7% there may be undetected parental mosaicism. There was an excess of female compared to male probands and a highly significant bias in the parental original of inherited mutations, with 20/21 found to be paternal in origin (95%). This could be because BPES in a female is more likely to come to clinical attention and because there is a generalised and more widespread clinical effect on fertility, in addition to the established association with POI. This study demonstrates the importance of cascade screening and provides new information on inheritance and parental mosaicism in BPES which will aid genetic counselling and accurate risk management. Crown
Copyright © 2019. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  DNA mutational analysis; Forkhead box protein L2; Paternal inheritance

Mesh:

Substances:

Year:  2019        PMID: 31077882     DOI: 10.1016/j.ejmg.2019.05.007

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  5 in total

1.  Ovarian Reserve and ART Outcomes in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Patients With FOXL2 Mutations.

Authors:  Tingting Meng; Wenzhe Zhang; Rongrong Zhang; Jie Li; Yuan Gao; Yingying Qin; Xue Jiao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-28       Impact factor: 6.055

2.  A novel FOXL2 mutation in two infertile patients with blepharophimosis-ptosis-epicanthus inversus syndrome.

Authors:  Jingmei Hu; Hanni Ke; Wei Luo; Yajuan Yang; Hongli Liu; Guangyu Li; Yingying Qin; Jinlong Ma; Shidou Zhao
Journal:  J Assist Reprod Genet       Date:  2019-12-10       Impact factor: 3.412

3.  A human paradigm of LHX4 and NR5A1 developmental gene interaction in the pituitary gland and ovary?

Authors:  Aristeidis Giannakopoulos; Amalia Sertedaki; Dionisios Chrysis
Journal:  Eur J Hum Genet       Date:  2022-03-11       Impact factor: 5.351

Review 4.  Confrontment and solution to gonadotropin resistance and low oocyte retrieval in in vitro fertilization for type I BPES: a case series with review of literature.

Authors:  Yiqi Yu; Mengxia Ji; Weihai Xu; Ling Zhang; Ming Qi; Jing Shu
Journal:  J Ovarian Res       Date:  2021-10-28       Impact factor: 4.234

Review 5.  The Genetic and Clinical Features of FOXL2-Related Blepharophimosis, Ptosis and Epicanthus Inversus Syndrome.

Authors:  Cécile Méjécase; Chandni Nigam; Mariya Moosajee; John C Bladen
Journal:  Genes (Basel)       Date:  2021-03-04       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.